- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Synthetic biology is developing into one of the most exciting fields in science and technology and is receiving increased attention from venture capitalists, government and university laboratories, major corporations, and startup companies. This emerging technology promises not only to enable cheap, lifesaving new drugs, but also to yield innovative biofuels that can help address the world's energy problems.
In an attempt to enable the technology's potential, some synthetic biologists are building their own brand of open source science. But as these researchers develop the necessary technological tools to realize synthetic biology's promises, there is as yet no legal framework to regulate the use and ownership of the information being created.
Will this open source movement succeed? Are life sciences companies ready for open source? What level of intellectual property (IP) protection is necessary to secure industry and venture capital involvement and promote innovation? And does open source raise broader social issues?
On June 17, the Synthetic Biology Project will kick off a series of events on approaches to IP. A panel of representatives from various sectors will discuss the major challenges to future IP developments related to synthetic biology, identify key steps to addressing these challenges, and examine a number of current tensions surrounding issues of use and ownership.
You must register to attend this event: www.synbioproject.org
No registration necessary to view the webcast
Synthetic Biology: Feasibility of the Open Source Movement
Wednesday, June 17, 2009, 12:30-1:30 PM (light lunch available at 12 noon)
Arti K. Rai, Elvin R. Latty Professor of Law, Duke Law School
Mark Bünger, Director of Research, Lux Research
Pat Mooney, Executive Director, ETC Group
David Rejeski, Moderator, Director, Synthetic Biology Project
5th Floor Conference Room, Woodrow Wilson International Center for Scholars - Directions
For more information, please click here
Copyright © Woodrow Wilson International Center for ScholarsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
How natural channel proteins move in artificial membranes June 3rd, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015